New York, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Nanobiotechnology Industry" - https://www.reportlinker.com/p04707106/?utm_source=GNW
8 Billion by 2027, growing at aCAGR of 7.1% over the period 2020-2027. Pharmaceuticals & Biotechnology Industry, one of the segments analyzed in the report, is projected to record 7.7% CAGR and reach US$68.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Medical Devices segment is readjusted to a revised 6% CAGR for the next 7-year period.
The U.S. Market is Estimated at $18.4 Billion, While China is Forecast to Grow at 6.6% CAGR
The Nanobiotechnology market in the U.S. is estimated at US$18.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$17.6 Billion by the year 2027 trailing a CAGR of 6.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.7% and 5.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.We bring years of research experience to this 17th edition of our report. The 163-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others,
- Ablynx NV
- Arrowhead Pharmaceuticals Inc.
- CaPtivate Pharmaceuticals LLC
- Celgene Corporation
- ELITechGroup
- Flamel Technologies SA
- GlaxoSmithKline Plc
- Johnson & Johnson
- Merck & Co. Inc.
- NanoBio® Corporation
- Nanophase Technologies Corporation
- pSivida Corp.
- Sigma-Aldrich Corp.
- Starpharma Holdings Ltd.
- Vectura Group plc
Read the full report: https://www.reportlinker.com/p04707106/?utm_source=GNW
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
A Curtain Raiser
Recent Market Activity
Nanobiotechnology - The Next Big Thing
An Insight into the Global Nanobiotechnology Market
Major Market Drivers
Where Conventional Molecular Science Falls Short Nanobio Steps In
Nanotechnology Revolutionizes Pharmaceuticals & Healthcare Sector
Nanomedicine Market to Achieve Phenomenal Growth
Opportunities Galore for Nanomedicine
Drug Delivery - A Promising Application Area for Nanotechnology
Nanotechnology Offers Huge Potential in Brain Disorder Treatment
High Demand for Nanobots and Nano Healthcare Devices
Nanotechnology Gaining Prominence for Treatment of Cancer
Nanotechnology in Drug Delivery: A Specialized Market Opportunity
Commercialization of Nanotechnology-based Medical Products
Gains Momentum
Nanodiagnostic Products to Witness Strong Demand Growth
Dendrimers Serve as a Base to Build Multifunctional Nanodevices
Nanotechnology Rescues Poor Water Soluble Drugs from Abandonment
Huge Opportunities for Nanomaterials in the Medical Field
Commercial Opportunities in Healthcare Sector
Future Possibilities
Global Market for Fullerenes - An Insight
Dawn Breaks on Nanobiotechnology
Demystifying the Intriguing World of Nanobiotech
A Meeting Place of Medicine?s Best Solutions
Nanobiotechnology to Become Viable for All Drug Development Stages
Nanoparticles: The Foundation of Nanobiotechnology
Improved Optical Properties and Stability of Nanoparticles
Nanoemulsions
The Promise of Nanobiotechnology
Biological Weaponries against Diseases Come in Small Packages
Proffered Benefits of Nanobiotechnology
Opportunity & Beyond
Nanobiotechnology - Will it Live Up to the Expectations?
The Future of Nanobiotechnology: Shape of Things to Come
Nanobiotechnology: The Outer Limits
Futuristics: A Rumination
Conclusions
Global Competitor Market Shares
Nanobiotechnology Competitor Market Share Scenario Worldwide:
( in %): 2018 & 2029
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
Ablynx NV (Belgium)
Arrowhead Pharmaceuticals, Inc. (USA)
Avadel Pharmaceuticals plc (Ireland)
CaPtivate Pharmaceuticals LLC (USA)
Celgene Corporation (USA)
ELITechGroup (France)
GlaxoSmithKline Plc. (UK)
Johnson & Johnson (USA)
Merck & Co., Inc. (USA)
NanoBio® Corporation (USA)
Nanophase Technologies Corporation (USA)
pSivida Corp. (USA)
Sigma-Aldrich Corp. (USA)
Starpharma Holdings Ltd. (Australia)
Vectura Group plc (UK)
3. MARKET TRENDS & DRIVERS
Present Status and Future Opportunities
Outlook
Developing Countries to Rise over the Horizon
Nanomaterials & Nanoparticles Witness Robust Activity
Focus on Improved Performance to Bring New Manufacturing
Methods for Nanomaterials
Why Invest in Nanobiotechnology?
Private and Public Companies to Step Up Funding on Nanotechnology
United States Lead the Way in Government Funding
Increasing Awareness on Technology to Drive Growth
Demand for Novel Products to Push Up Growth
Nano-Enabled Drug Discovery Holds Tremendous Potential
Consolidation Sharpens the Industry’s Edge
The Regulatory Framework Evolves with the Technology
Quantum Dot Patents Pose Legal Tangles
Miniaturized Liquid Handling Becomes Progressive
Trends in Nanotechnology Enabled Drug Delivery Systems
Patent Expiries: A Key Driver
Nanotechnology Enabled Drug Delivery to Exhume Unused Drugs
4. GLOBAL MARKET PERSPECTIVE
Table 1: Nanobiotechnology Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2020-2027
Table 2: Nanobiotechnology Global Retrospective Market Scenario
in US$ Million by Region/Country: 2012-2019
Table 3: Nanobiotechnology Market Share Shift across Key
Geographies Worldwide: 2012 VS 2020 VS 2027
Table 4: Pharmaceuticals & Biotechnology Industry (End-Use)
Global Opportunity Assessment in US$ Million by Region/Country:
2020-2027
Table 5: Pharmaceuticals & Biotechnology Industry (End-Use)
Historic Sales Analysis in US$ Million by Region/Country:
2012-2019
Table 6: Pharmaceuticals & Biotechnology Industry (End-Use)
Percentage Share Breakdown of Global Sales by Region/Country:
2012 VS 2020 VS 2027
Table 7: Medical Devices (End-Use) Worldwide Sales in US$
Million by Region/Country: 2020-2027
Table 8: Medical Devices (End-Use) Historic Demand Patterns in
US$ Million by Region/Country: 2012-2019
Table 9: Medical Devices (End-Use) Market Share Shift across
Key Geographies: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Nanobiotechnology Market Share (in %) by Company: 2018 & 2025
Market Analytics
Table 10: United States Nanobiotechnology Latent Demand
Forecasts in US$ Million by End-Use: 2020 to 2027
Table 11: Nanobiotechnology Historic Demand Patterns in the
United States by End-Use in US$ Million for 2012-2019
Table 12: Nanobiotechnology Market Share Breakdown in the
United States by End-Use: 2012 VS 2020 VS 2027
CANADA
Table 13: Canadian Nanobiotechnology Market Quantitative Demand
Analysis in US$ Million by End-Use: 2020 to 2027
Table 14: Nanobiotechnology Market in Canada: Summarization of
Historic Demand Patterns in US$ Million by End-Use for
2012-2019
Table 15: Canadian Nanobiotechnology Market Share Analysis by
End-Use: 2012 VS 2020 VS 2027
JAPAN
Table 16: Japanese Demand Estimates and Forecasts for
Nanobiotechnology in US$ Million by End-Use: 2020 to 2027
Table 17: Japanese Nanobiotechnology Market in US$ Million by
End-Use: 2012-2019
Table 18: Nanobiotechnology Market Share Shift in Japan by
End-Use: 2012 VS 2020 VS 2027
CHINA
Table 19: Chinese Demand for Nanobiotechnology in US$ Million
by End-Use: 2020 to 2027
Table 20: Nanobiotechnology Market Review in China in US$
Million by End-Use: 2012-2019
Table 21: Chinese Nanobiotechnology Market Share Breakdown by
End-Use: 2012 VS 2020 VS 2027
EUROPE
Market Facts & Figures
European Nanobiotechnology Market: Competitor Market Share
Scenario (in %) for 2018 & 2025
Market Analytics
Table 22: European Nanobiotechnology Market Demand Scenario in
US$ Million by Region/Country: 2020-2027
Table 23: Nanobiotechnology Market in Europe: A Historic Market
Perspective in US$ Million by Region/Country for the Period
2012-2019
Table 24: European Nanobiotechnology Market Share Shift by
Region/Country: 2012 VS 2020 VS 2027
Table 25: European Nanobiotechnology Addressable Market
Opportunity in US$ Million by End-Use: 2020-2027
Table 26: Nanobiotechnology Market in Europe: Summarization of
Historic Demand in US$ Million by End-Use for the Period
2012-2019
Table 27: European Nanobiotechnology Market Share Analysis by
End-Use: 2012 VS 2020 VS 2027
FRANCE
Table 28: Nanobiotechnology Quantitative Demand Analysis in
France in US$ Million by End-Use: 2020-2027
Table 29: French Nanobiotechnology Historic Market Review in
US$ Million by End-Use: 2012-2019
Table 30: French Nanobiotechnology Market Share Analysis:
A 17-Year Perspective by End-Use for 2012, 2020, and 2027
GERMANY
Table 31: Nanobiotechnology Market in Germany: Annual Sales
Estimates and Forecasts in US$ Million by End-Use for the
Period 2020-2027
Table 32: German Nanobiotechnology Market in Retrospect in US$
Million by End-Use: 2012-2019
Table 33: Nanobiotechnology Market Share Distribution in
Germany by End-Use: 2012 VS 2020 VS 2027
ITALY
Table 34: Italian Demand for Nanobiotechnology in US$ Million
by End-Use: 2020 to 2027
Table 35: Nanobiotechnology Market Review in Italy in US$
Million by End-Use: 2012-2019
Table 36: Italian Nanobiotechnology Market Share Breakdown by
End-Use: 2012 VS 2020 VS 2027
UNITED KINGDOM
Table 37: United Kingdom Demand Estimates and Forecasts for
Nanobiotechnology in US$ Million by End-Use: 2020 to 2027
Table 38: United Kingdom Nanobiotechnology Market in US$
Million by End-Use: 2012-2019
Table 39: Nanobiotechnology Market Share Shift in the United
Kingdom by End-Use: 2012 VS 2020 VS 2027
REST OF EUROPE
Table 40: Rest of Europe Nanobiotechnology Addressable Market
Opportunity in US$ Million by End-Use: 2020-2027
Table 41: Nanobiotechnology Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019
Table 42: Rest of Europe Nanobiotechnology Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027
ASIA-PACIFIC
Table 43: Nanobiotechnology Quantitative Demand Analysis in
Asia-Pacific in US$ Million by End-Use: 2020-2027
Table 44: Asia-Pacific Nanobiotechnology Historic Market Review
in US$ Million by End-Use: 2012-2019
Table 45: Asia-Pacific Nanobiotechnology Market Share Analysis:
A 17-Year Perspective by End-Use for 2012, 2020, and 2027
REST OF WORLD
Table 46: Rest of World Nanobiotechnology Market Quantitative
Demand Analysis in US$ Million by End-Use: 2020 to 2027
Table 47: Nanobiotechnology Market in Rest of World:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2012-2019
Table 48: Rest of World Nanobiotechnology Market Share Analysis
by End-Use: 2012 VS 2020 VS 2027
IV. COMPETITION
Total Companies Profiled: 79
Read the full report: https://www.reportlinker.com/p04707106/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________